Esta página no está disponible en el idioma seleccionado Spanish : Español y la proponemos por consiguiente en English : English.

COVID-19 vaccines distribution across borders

In November 2020, the world witnessed the first announcements of COVID-19 vaccine candidates proving to be more than 90% effective based on first interim analysis of Phase 3 clinical trials results.

By that time, the vaccine distribution supply chain stakeholders had started their preparations for what is expected to be the world’s largest and fastest vaccine distribution operation ever.

This section of the WCO web-site is designed to compile information about the tools, guidance materials and best practices that can support our Members and their stakeholders worldwide to support the COVID-19 vaccine distribution effort by facilitating the cross-border movement of vaccines and situationally critical medicines, while protecting people from dangerous, sub-standard or counterfeit medicines and vaccines.

WCO Members’ practices in facilitating the cross-border movement of COVID-19 vaccines

On 14 January 2021, as a follow-up action to the December 2020 Council Resolution, the WCO Secretary General wrote to all WCO Members inviting them to share information and/or good practices on facilitating the cross-border movement of COVID-19 vaccines. A template for the submissions was enclosed to the letter. Below you can find national practices submitted by WCO Member Customs administrations.